Incidence of urticaria, angioedema, and type I hypersensitivity reactions associated with fibrinolytic agents in Thailand using the database of the health product vigilance center | Zendy

Hutsaya Prasitdumrong | Zendy; Kawin Duangmee | Zendy; Pornwalai Boonmuang | Zendy; Wichai Santimaleeworagun | Zendy; Yaowares Oppamayun | Zendy; Cholticha Sonsupap | Zendy; Thawatchai Nakkaratniyom | Zendy

Open Access

Incidence of urticaria, angioedema, and type I hypersensitivity reactions associated with fibrinolytic agents in Thailand using the database of the health product vigilance center

Author(s) -

Hutsaya Prasitdumrong,

Kawin Duangmee,

Pornwalai Boonmuang,

Wichai Santimaleeworagun,

Yaowares Oppamayun,

Cholticha Sonsupap,

Thawatchai Nakkaratniyom

Publication year - 2020

Publication title -

asian pacific journal of allergy and immunology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.405

H-Index - 33

ISSN - 0125-877X

DOI - 10.12932/ap-181119-0694

Subject(s) - angioedema , medicine , incidence (geometry) , anaphylaxis , hypersensitivity reaction , allergy , drug allergy , dermatology , immunology , physics , optics

Besides hemorrhage, allergic reactions have also been observed in several clinical trials of fibrinolytic agents. These reactions might negatively affect patient outcomes, especially life-threatening type I hypersensitivity reactions such as anaphylaxis. However, there are limited data on the incidence of these reactions.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research